Here are five insights:
1. Ms. Cohen purchased the stock at an average cost of $40 per share.
2. The total cost of the shares was $17,600.
3. With this purchase, Ms. Cohen owns 11,291 company shares totaling about $441,640.
4. Conmed disclosed this transaction in a legal filing with the Securities and Exchange Commission.
5. The company has a market capitalization of $1.21 billion and a P/E ratio of 83.65.
More articles on devices:
CyMedica Orthopedics enrolls 1st patient in clinical rehabilitation trial — 4 details
AdvaMed adds Rotation Medical CEO Martha Shadan to board of directors — 5 takeaways
AdvaMed Chairman Nadim Yared on why small device companies struggle to succeed: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
